PharmEasy flags typhoid as India’s leading confirmed monsoon fever risk
PharmEasy’s Fever Watch reported 25.5% typhoid test positivity through August 12, ahead of dengue at 8.5%. Its national fever-risk score rose to 61 from 47 at the start of the monsoon, with 10 cities classified high risk.
What happened
PharmEasy’s Fever Watch found typhoid had India’s highest monsoon test positivity at 25.5%, with seven of 10 high-risk cities driven by typhoid. Its tracked
Key facts
- Typhoid test positivity: 25.5%
- Dengue test positivity: 8.5%
- Chikungunya test positivity: 1.8%
- Malaria test positivity: 1.4%
- 209 cities tracked
- 186 cities showed higher risk than season start
- 10 cities classified HIGH risk
- 7 HIGH-risk cities driven by typhoid
- National fever-risk score: 61, versus 47 at season start
- Weather and breeding signal: 87, versus 48 at season start
- 14-day national rainfall: approximately 133 mm, versus approximately 35 mm at season start
- Panaji overall risk score: 94
- Bokaro overall risk score: 79
- Gwalior overall risk score: 78
Why this matters
PharmEasy’s fever-risk dataset could strengthen partnership or acquisition cases in diagnostics, lab networks, teleconsultation and hyperlocal health-delivery capabilities.
What to watch
- Weekly typhoid, dengue and malaria test positivity by city and test-volume growth versus the prior monsoon period.
- Rainfall intensity, flooding, water-contamination alerts and municipal vector-control actions in high-risk cities.
- Diagnostic turnaround times, sample-collection slot availability and stockouts of fever-related OTC products.
- Teleconsult-to-test and test-to-prescription conversion rates, including antibiotic fulfillment patterns.
- Regulatory or medical-body advisories on typhoid testing accuracy, antimicrobial resistance and antibiotic dispensing.
- Prioritize fever-test inventory, home sample-collection capacity and rapid appointment slots in the 10 high-risk cities.
- Bundle teleconsultation, diagnostic testing and prescription fulfillment while maintaining antibiotic stewardship and prescription verification.
- Increase availability and targeted promotion of ORS, hydration products, thermometers, mosquito repellents, water purifiers and sanitation essentials.
- Use city-level risk scores to rebalance last-mile delivery staffing, laboratory capacity and local marketing spend.
- Monitor customer service scripts and clinical escalation protocols to avoid self-medication and reputational risk around typhoid treatment.